Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 548,792 |
|
|||||
| News | - | ||||||
| Day High | 1.1097 | Low High |
|||||
| Day Low | 0.8366 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Xilio Therapeutics Inc | XLO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.1051 | -10.01% | 0.9449 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.05 | 0.8366 | 1.1097 | 0.9173 | 1.05 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,267 | 548,792 | $ 0.9435962 | $ 517,838 | - | 0.49 - 3.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:08 | 1 | $ 0.9001 | USD |
Xilio Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 25.06M | 27.54M | - | 0 | -76.4M | -2.77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Xilio Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XLO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.23 | 1.2599 | 0.8366 | 1.13 | 133,042 | -0.2851 | -23.18% |
| 1 Month | 1.01 | 1.32 | 0.8366 | 1.16 | 184,267 | -0.0651 | -6.45% |
| 3 Months | 0.7153 | 1.93 | 0.58 | 1.24 | 1,303,300 | 0.2296 | 32.10% |
| 6 Months | 1.17 | 1.93 | 0.49 | 1.15 | 719,062 | -0.2251 | -19.24% |
| 1 Year | 3.09 | 3.25 | 0.49 | 1.18 | 365,036 | -2.15 | -69.42% |
| 3 Years | 15.00 | 27.95 | 0.49 | 2.68 | 187,151 | -14.06 | -93.70% |
| 5 Years | 15.00 | 27.95 | 0.49 | 2.68 | 187,151 | -14.06 | -93.70% |
Xilio Therapeutics Description
| Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. The goal is to overcome the limitations of current I-O therapies by developing products with an improved therapeutic index. |
